The development of bladder tumors and contralateral upper urinary tract tumors after primary transitional cell carcinoma of the upper urinary tract
β Scribed by Chih-Hsiung Kang; Tsan-Jung Yu; Hwei-Ho Hsieh; Joseph W. Yang; Kenneth Shu; Chao-Cheng Huang; Po-Huang Chiang; Yow-Ling Shiue
- Publisher
- John Wiley and Sons
- Year
- 2003
- Tongue
- English
- Weight
- 100 KB
- Volume
- 98
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
BACKGROUND
Contralateral, metachronous upper urinary tract (UUT) tumors after primary transitional cell carcinoma (TCC) of the UUT are reported rarely, and to the authors' knowledge the risk factors have not been determined to date. In addition, few reports have described the characteristics of recurrent bladder tumors and contralateral UUT tumors and any relation between theses tumor types.
METHODS
Statistical analysis of data from 223 patients with documented primary UUTβTCC was undertaken. After excluding bilateral involvement and distant metastases, 12 variables were analyzed by multivariate analysis in 189 patients to determine the risk factors for recurrent urothelial tumors.
RESULTS
The incidence rates of recurrent bladder tumors and contralateral UUT tumors were 31.2% and 5.8%, respectively. Multiplicity was determined as a risk factor for recurrent bladder tumors. Renal insufficiency, uremia, and concurrent bladder tumors significantly predisposed patients to develop contralateral UUT tumors after primary UUTβTCC. The time intervals and stage distributions differed significantly between recurrent bladder tumors and contralateral UTT tumors. Patients who had recurrent bladder tumors had earlier stage tumors and had a shorter time to recur compared with patients who had contralateral, metachronous UUT tumors.
CONCLUSIONS
For patients with primary UUTβTCC, regular followβup by cystoscopy is necessary to detect recurrent bladder tumors. Intravenous urography or retrograde pyelography should be performed for patients who have a high risk of developing contralateral UUT tumors. Cancer 2003. Β© 2003 American Cancer Society.
DOI 10.1002/cncr.11691
π SIMILAR VOLUMES
A retrospective analysis of 74 cases of transitional cell carcinoma of the renal pelvis and ureter treated at this institution over the past 30 years is presented. When nephrectomy alone or incomplete nephroureterectomy was performed, subsequent transitional cell carcinoma developed in 30% of the ur
## Abstract ## BACKGROUND The efficacy and longβterm results of endoscopic management of upper tract transitional cell carcinoma (TCC) were examined. The authors evaluated the accuracy of endoscopic biopsy in determining tumor grade in the subset of patients who underwent open surgical excision.
The authors are indebted to Geron Corporation, Menlo Park, CA, for the gift of a human telomerase RNA component (hTR) probe; Dr.
The pathologic material and medical records of 76 patients with primary upper urinary tract carcinomas were reviewed to identify the role of grade and stage in predicting survival: to determine any differences in survival between ureteral and renal pelvic carcinoma; to understand the role of local t